Hints and tips:
Related Special Reports
...The review was partly sparked by AstraZeneca’s decision in February to build a $360mn factory in Ireland rather than Britain, with the pharmaceutical company lamenting the UK’s “discouraging tax rate”....
...Vaxxers, Professor Sarah Gilbert and Catherine Green’s memoir of developing the Oxford AstraZeneca vaccine, describes the sequence being posted online late on a Friday night, with more genomes appearing...
...Oxford and AstraZeneca did not respond to requests for comment....
...Regeneron has also partnered with AstraZeneca for its expertise in chemistry, to make a pill, and with Boston-based Alnylam Pharmaceuticals, to use its novel way of silencing genes, called RNA interference...
...This contrasts with the trend of monopoly pricing in the pharmaceutical industry and strategic patenting to block competitors....
...“Employers are crying out for digital and green skills across all sectors.”...
...In the past decade, the world-class research coming out of Cambridge’s colleges has driven a boom in industries such as pharmaceuticals and technology....
...Temperatures rising above the optimal 1.5C could also result in profound health effects, says Juliette White, vice-president of sustainability at pharmaceutical group AstraZeneca....
...The changes are conditional upon AstraZeneca finalising its purchase of Alexion, likely in the third quarter....
...follow suit, which could dramatically increase demand for Pfizer and Moderna’s messenger RNA vaccines in countries which have otherwise predominantly used viral vector shots such as that made by Oxford/AstraZeneca.Janet...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...for the world” with AstraZeneca....
...The green bond market “potentially has a big role to play” in financing the transition for cities, HSBC wrote....
...Two other local companies have also signed deals to produce Gamaleya’s Sputnik V vaccine later this month....
...Adenovirus-based vaccines, such as Gamaleya’s Sputnik V, Oxford-AstraZeneca’s and Johnson & Johnson’s, for example, are limited by how much information they can hold and what the vaccines can be instructed...
...A committee of Indian pharmaceutical and medical experts has recommended the use of Russia’s Sputnik V coronavirus vaccine to alleviate pressure on the country’s limited supplies as it faces a second wave...
...So called “real-world” analysis of 14,019 cases of the Delta variant in the UK, released by Public Health England in June, found the BioNTech/Pfizer and Oxford/AstraZeneca vaccines were, respectively, 96...
...Most Indians have received Covishield, the Oxford/AstraZeneca shot manufactured by the Serum Institute of India, the world’s largest vaccine maker....
...The Oxford/AstraZeneca jab is also being deployed....
...“We have more vaccinated people here, Pfizer seems to provide better defence than [AstraZeneca], and I don’t believe the government will allow the virus to run rampant....
...The UK drugmaker has not applied for authorisation in the US, although it has already made millions of doses ready to ship when it receives the green light from the US drugs regulator....
...Several companies in India, a global pharmaceuticals hub, have signed on to manufacture Sputnik V....
...Most European countries resumed use of the vaccine after it was given the green light from European regulators last week although some, such as Sweden and Finland, have restricted it to only the oldest people...
...The AstraZeneca and J&J shots are both adenoviral vector vaccines — as are Russia’s Sputnik V jab and the shot developed by China’s CanSino Biologics — meaning they use an adenovirus, such as the common...
...Brazil’s health regulator has given the green light to the Oxford/AstraZeneca and Chinese-made Sinovac coronavirus vaccines, paving the way for Latin America’s largest nation to begin an immunisation programme...
International Edition